miRNA-378 reverses chemoresistance to cisplatin in lung adenocarcinoma cells by targeting secreted clusterin-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

miRNA-378 reverses chemoresistance to cisplatin in lung adenocarcinoma cells by targeting secreted clusterin

Published:2016-01-19 Issue:1 Volume:6 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Chen Xuesong,Jiang Ying,Huang Zheping,Li Dandan,Chen Xiaodi,Cao Mengru,Meng Qingwei,Pang Hui,Sun Lichun,Zhao Yanbin,Cai Li

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep19455.pdf

Reference38 articles.

1. Jemal, A. et al. Cancer statistics, 2009. CA Cancer J Clin. 59, 225–249 (2009).

2. Reck, M., Heigener, D. F., Mok, T., Soria, J. C. & Rabe, K. F. Management of non-small-cell lung cancer: recent developments. Lancet. 382, 709–719 (2013).

3. Davidoff, A. J., Tang, M., Seal, B. & Edelman, M. J. Chemotherapy and survival benefit in elderly patients with advanced non-small-cell lung cancer. J Clin Oncol. 28, 2191–2197 (2010).

4. Lee, C. H. et al. Suppression of clusterin expression enhanced cisplatin-induced cytotoxicity on renal cell carcinoma cells. Urology. 60, 516–520 (2002).

5. Hoeller, C. et al. Clusterin regulates drug-resistance in melanoma cells. J Invest Dermatol. 124, 1300–1307 (2005).

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic Potential of Clusterin Inhibition in Human Cancer;Cells;2024-04-10

2. CLUSTERIN: A DOUBLE-EDGED SWORD IN CANCER AND NEUROLOGICAL DISORDERS;EXCLI J;2024

3. The Ins and Outs of Clusterin: Its Role in Cancer, Eye Diseases and Wound Healing;International Journal of Molecular Sciences;2023-08-24

4. Emerging role of non-coding RNAs in resistance to platinum-based anti-cancer agents in lung cancer;Frontiers in Pharmacology;2023-01-26

5. Dysregulation of HNF1B/Clusterin axis enhances disease progression in a highly aggressive subset of pancreatic cancer patients;Carcinogenesis;2022-11-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3